BTIG Maintains Buy on ICU Medical, Raises Price Target to $200

Benzinga Newsdesk www.benzinga.com Positive 80.2%

Neg 0% Neu 0% Pos 80.2%

BTIG analyst Sam Eiber maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $170 to $200.

Comments

No comments yet. Be the first!